Bulletin 199 launched - Oxycodone/naloxone (Targinact®)
This bulletin supports the implementation of the NHS England guidance on low priority prescribing. It supports the review of oxycodone/naloxone prolonged release tablets, the rationale to stop treatment and also suggests alternative treatment options. Support materials are also available for organisations to adapt and use to implement changes.
